Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1968 2
1970 1
1973 1
1974 1
1976 7
1977 4
1978 12
1979 16
1980 16
1981 14
1982 10
1983 22
1984 14
1985 21
1986 31
1987 22
1988 27
1989 35
1990 15
1991 22
1992 23
1993 24
1994 17
1995 14
1996 15
1997 14
1998 15
1999 14
2000 18
2001 23
2002 11
2003 16
2004 15
2005 16
2006 30
2007 21
2008 18
2009 16
2010 21
2011 16
2012 9
2013 14
2014 16
2015 19
2016 11
2017 18
2018 28
2019 25
2020 14
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

778 results
Results by year
Filters applied: . Clear all
Page 1
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K, Koike-Yusa H, De Braekeleer E, Li Y, Metzakopian E, Dovey OM, Mupo A, Grinkevich V, Li M, Mazan M, Gozdecka M, Ohnishi S, Cooper J, Patel M, McKerrell T, Chen B, Domingues AF, Gallipoli P, Teichmann S, Ponstingl H, McDermott U, Saez-Rodriguez J, Huntly BJP, Iorio F, Pina C, Vassiliou GS, Yusa K. Tzelepis K, et al. Among authors: ohnishi s. Cell Rep. 2016 Oct 18;17(4):1193-1205. doi: 10.1016/j.celrep.2016.09.079. Cell Rep. 2016. PMID: 27760321 Free PMC article.
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.
Kitagataya T, Suda G, Nagashima K, Katsurada T, Yamamoto K, Kimura M, Maehara O, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Umemura M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Komatsu Y, Hata H, Takeuchi S, Abe T, Sakakibara-Konishi J, Teshima T, Homma A, Sakamoto N. Kitagataya T, et al. Among authors: ohnishi s. J Gastroenterol Hepatol. 2020 Oct;35(10):1782-1788. doi: 10.1111/jgh.15041. Epub 2020 Mar 31. J Gastroenterol Hepatol. 2020. PMID: 32187734
[Ghrelin].
Ohnishi S, Nagaya N, Kangawa K. Ohnishi S, et al. Nihon Rinsho. 2007 Apr 28;65 Suppl 4:186-90. Nihon Rinsho. 2007. PMID: 17508556 Review. Japanese. No abstract available.
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.
Shigesawa T, Maehara O, Suda G, Natsuizaka M, Kimura M, Shimazaki T, Yamamoto K, Yamada R, Kitagataya T, Nakamura A, Suzuki K, Ohara M, Kawagishi N, Umemura M, Nakai M, Sho T, Morikawa K, Ogawa K, Ohnishi S, Sugiyama M, Mizokami M, Takeda H, Sakamoto N. Shigesawa T, et al. Among authors: ohnishi s. Carcinogenesis. 2021 Feb 11;42(1):58-69. doi: 10.1093/carcin/bgaa049. Carcinogenesis. 2021. PMID: 32449510
778 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page